Literature DB >> 9596608

Intermittent low dose prednisolone is safe in rheumatoid arthritis.

P C Gøtzsche, H K Johansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9596608      PMCID： PMC1113209          DOI： 10.1136/bmj.316.7144.1606a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Authors:  M Boers; A C Verhoeven; H M Markusse; M A van de Laar; R Westhovens; J C van Denderen; D van Zeben; B A Dijkmans; A J Peeters; P Jacobs; H R van den Brink; H J Schouten; D M van der Heijde; A Boonen; S van der Linden
Journal:  Lancet       Date:  1997-08-02       Impact factor: 79.321

2.  Corticosteroids in rheumatoid arthritis.

Authors:  E M Dennison; C Cooper
Journal:  BMJ       Date:  1998-03-14

3.  Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

Authors:  P C Gøtzsche; H K Johansen
Journal:  BMJ       Date:  1998-03-14

4.  Limited bone loss due to corticosteroids; a systematic review of prospective studies in rheumatoid arthritis and other diseases.

Authors:  A C Verhoeven; M Boers
Journal:  J Rheumatol       Date:  1997-08       Impact factor: 4.666

Review 5.  Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis.

Authors:  R Eastell
Journal:  J Intern Med       Date:  1995-05       Impact factor: 8.989
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.